Mechanism & Scope Fit (molcell-fit)
Why this is skill #1
Molecular Cell triages most submissions to rejection without external review. The gate is not "is it correct" and not "is it interesting" — it is "is the molecular mechanism worked out, proven by independent methods, and shown to matter in a physiological setting." A striking phenotype with a proposed-but-unproven mechanism is desk-rejected. Run this before writing a word.
When to trigger
- Before drafting, to decide if Molecular Cell is the right Cell Press venue.
- When a co-author says "this is a Molecular Cell paper" and you need a sober check.
- When choosing among Molecular Cell, Cell, Cell Reports, and the strong field competitors (NSMB, EMBO J, Genes & Dev, Nucleic Acids Research).
Molecular Cell's home domains
Molecular Cell publishes mechanism in a defined set of areas. Confirm your work sits squarely in one:
- Gene expression — transcription, RNA Pol I/II/III mechanism, splicing, translation.
- Chromatin & epigenetics — nucleosome dynamics, histone modification, remodelers, 3D genome.
- RNA biology — ncRNA, RNA modification, RNP assembly, decay, RNA–protein interactions.
- DNA replication, repair & recombination — replisome, damage response, checkpoint.
- Signaling — molecular logic of a pathway at the level of the modified residue.
- Proteostasis — folding, degradation (UPS, autophagy), stress responses, condensates.
- Protein structure/function — structure used to decide a mechanism, not to describe a fold.
If the work is molecular but has no deep mechanism, or is broad but shallow, reconsider the venue.
The "deep mechanism" test
Molecular Cell wants the how nailed down. Ask:
- Mechanism: do you explain the molecular event (which residue, base, bond, interface, step) — not just the pathway cartoon?
- Orthogonality: do ≥2 independent approaches converge — e.g., biochemistry + structure, genetics + genomics, single-molecule + reconstitution?
- Causality: separation-of-function or point-mutant evidence that ties the mechanism to the phenotype (not just knockout of the whole protein)?
- Physiological relevance: does the mechanism operate in cells/organisms, not only in the tube?
- Reconstitution (where feasible): can you rebuild the activity from defined components?
If mechanism / orthogonality / causality / physiological relevance are not all addressed, it is likely not yet a Molecular Cell paper — name the experiment that closes the gap.
Mechanistic-depth ladder (weak → strong)
- Reports a phenotype or correlation, mechanism proposed only. (Weak — not Mol. Cell.)
- Localizes the effect to a protein/complex without the molecular step. (Borderline — Cell Reports.)
- Defines the molecular mechanism with one strong approach + validation. (Strong — Molecular Cell.)
- Reconstitutes/visualizes the mechanism with orthogonal biochemistry + structure/single-molecule and separation-of-function mutants. (Strongest — Molecular Cell.)
- Rewrites the accepted molecular model of a process with decisive, multi-angle evidence. (Cell or Molecular Cell.)
If you cannot place the work at rung 3+ with orthogonal validation, Molecular Cell is a long shot — name the realistic venue honestly.
Fatal pre-review-reject triggers
- Descriptive / correlative — a phenotype or ChIP/RNA-seq correlation with no molecular cause.
- Single technique carrying the whole mechanistic claim.
- Mechanism asserted, not demonstrated — a model cartoon unsupported by point mutants or reconstitution.
- Over-interpreted structure — a coordinate set with functional claims the data don't test.
- No physiological validation — an in-vitro activity never shown to matter in cells/in vivo.
- No reagent/data transparency — undeposited data, unshared constructs, no RRIDs.
- Scope mismatch — broad significance but shallow mechanism → Cell, not Molecular Cell.
Venue routing within Cell Press and beyond
| Situation |
Recommend |
| Rung 3–5, deep mechanism, orthogonal validation, physiological |
Molecular Cell (Article) |
| Rung 4–5 and broad cross-field significance / complete story |
also consider Cell |
| Solid and complete but mechanism not deep / less rigorous |
Cell Reports (more accepting) |
| One decisive, fully validated mechanistic point, compact |
Molecular Cell Short Article |
| Structure-led mechanism, specialist depth |
NSMB / Structure |
| Mechanism localized but not yet molecular |
add point-mutant / reconstitution before submitting |
Output format
【Depth rung】 1–5 + one-line justification
【Deep-mechanism test】 mechanism / orthogonality / causality / physiological / reconstitution → which are met
【Domain fit】 which Mol. Cell home domain (or scope mismatch)
【Fatal triggers present】 [...]
【Recommended venue】 Molecular Cell / Cell / Cell Reports / NSMB-EMBO / other
【If staying with Mol. Cell, the one-line mechanistic advance】 "..."
【Gap-closing experiment, if any】 ...
【Next】 molcell-framing (if pass) | reconsider venue (if fail)
Anti-patterns
- Do not mistake a strong phenotype for a mechanism — Molecular Cell wants the molecular step.
- Do not call two runs of the same assay "orthogonal validation."
- Do not confuse a beautiful structure with a tested mechanism.
- Do not let sunk cost drive the venue call; Cell Reports is an honest landing spot.
Confirm scope expectations against the current Molecular Cell information-for-authors page and recent issues.
1---2name: molcell-fit3description: Use when triaging a study before any writing — stress-tests whether it clears Molecular Cell's bar (a deep molecular mechanism proven by orthogonal approaches with physiological relevance) or belongs at a sibling. Use this first to decide Molecular Cell vs Cell vs Cell Reports vs NSMB/EMBO J before investing in framing or figures.4---56# Mechanism & Scope Fit (molcell-fit)78## Why this is skill #1910Molecular Cell triages **most submissions to rejection without external review**. The gate is not "is it correct" and not "is it interesting" — it is **"is the molecular mechanism worked out, proven by independent methods, and shown to matter in a physiological setting."** A striking phenotype with a proposed-but-unproven mechanism is desk-rejected. Run this before writing a word.1112## When to trigger1314- Before drafting, to decide if Molecular Cell is the right Cell Press venue.15- When a co-author says "this is a Molecular Cell paper" and you need a sober check.16- When choosing among Molecular Cell, Cell, Cell Reports, and the strong field competitors (NSMB, EMBO J, Genes & Dev, Nucleic Acids Research).1718## Molecular Cell's home domains1920Molecular Cell publishes mechanism in a defined set of areas. Confirm your work sits squarely in one:2122- **Gene expression** — transcription, RNA Pol I/II/III mechanism, splicing, translation.23- **Chromatin & epigenetics** — nucleosome dynamics, histone modification, remodelers, 3D genome.24- **RNA biology** — ncRNA, RNA modification, RNP assembly, decay, RNA–protein interactions.25- **DNA replication, repair & recombination** — replisome, damage response, checkpoint.26- **Signaling** — molecular logic of a pathway at the level of the modified residue.27- **Proteostasis** — folding, degradation (UPS, autophagy), stress responses, condensates.28- **Protein structure/function** — structure used to *decide* a mechanism, not to describe a fold.2930If the work is molecular but has no deep mechanism, or is broad but shallow, reconsider the venue.3132## The "deep mechanism" test3334Molecular Cell wants the *how* nailed down. Ask:3536- **Mechanism:** do you explain the molecular event (which residue, base, bond, interface, step) — not just the pathway cartoon?37- **Orthogonality:** do **≥2 independent approaches** converge — e.g., biochemistry + structure, genetics + genomics, single-molecule + reconstitution?38- **Causality:** separation-of-function or point-mutant evidence that ties the mechanism to the phenotype (not just knockout of the whole protein)?39- **Physiological relevance:** does the mechanism operate in cells/organisms, not only in the tube?40- **Reconstitution (where feasible):** can you rebuild the activity from defined components?4142If mechanism / orthogonality / causality / physiological relevance are not all addressed, it is likely **not yet** a Molecular Cell paper — name the experiment that closes the gap.4344## Mechanistic-depth ladder (weak → strong)45461. **Reports** a phenotype or correlation, mechanism proposed only. (Weak — not Mol. Cell.)472. **Localizes** the effect to a protein/complex without the molecular step. (Borderline — Cell Reports.)483. **Defines** the molecular mechanism with one strong approach + validation. (Strong — Molecular Cell.)494. **Reconstitutes/visualizes** the mechanism with orthogonal biochemistry + structure/single-molecule and separation-of-function mutants. (Strongest — Molecular Cell.)505. **Rewrites** the accepted molecular model of a process with decisive, multi-angle evidence. (Cell or Molecular Cell.)5152If you cannot place the work at rung 3+ with orthogonal validation, Molecular Cell is a long shot — name the realistic venue honestly.5354## Fatal pre-review-reject triggers5556- **Descriptive / correlative** — a phenotype or ChIP/RNA-seq correlation with no molecular cause.57- **Single technique** carrying the whole mechanistic claim.58- **Mechanism asserted, not demonstrated** — a model cartoon unsupported by point mutants or reconstitution.59- **Over-interpreted structure** — a coordinate set with functional claims the data don't test.60- **No physiological validation** — an in-vitro activity never shown to matter in cells/in vivo.61- **No reagent/data transparency** — undeposited data, unshared constructs, no RRIDs.62- **Scope mismatch** — broad significance but shallow mechanism → *Cell*, not Molecular Cell.6364## Venue routing within Cell Press and beyond6566| Situation | Recommend |67|------------------------------------------------------------------------|---------------------------|68| Rung 3–5, deep mechanism, orthogonal validation, physiological | **Molecular Cell** (Article) |69| Rung 4–5 **and** broad cross-field significance / complete story | also consider **Cell** |70| Solid and complete but mechanism not deep / less rigorous | **Cell Reports** (more accepting) |71| One decisive, fully validated mechanistic point, compact | **Molecular Cell Short Article** |72| Structure-led mechanism, specialist depth | **NSMB / Structure** |73| Mechanism localized but not yet molecular | add point-mutant / reconstitution before submitting |7475## Output format7677```78【Depth rung】 1–5 + one-line justification79【Deep-mechanism test】 mechanism / orthogonality / causality / physiological / reconstitution → which are met80【Domain fit】 which Mol. Cell home domain (or scope mismatch)81【Fatal triggers present】 [...]82【Recommended venue】 Molecular Cell / Cell / Cell Reports / NSMB-EMBO / other83【If staying with Mol. Cell, the one-line mechanistic advance】 "..."84【Gap-closing experiment, if any】 ...85【Next】 molcell-framing (if pass) | reconsider venue (if fail)86```8788## Anti-patterns8990- **Do not** mistake a strong phenotype for a mechanism — Molecular Cell wants the molecular step.91- **Do not** call two runs of the same assay "orthogonal validation."92- **Do not** confuse a beautiful structure with a tested mechanism.93- **Do not** let sunk cost drive the venue call; Cell Reports is an honest landing spot.9495> Confirm scope expectations against the current Molecular Cell information-for-authors page and recent issues.